Longitudinal regret after treatment for low ‐ and intermediate‐risk prostate cancer
CONCLUSIONIn the context of a multidisciplinary clinic, decisional regret did not differ significantly between treatment groups but was greater in African Americans and those reporting poorer HRQoL. Cancer 2017. © 2017 American Cancer Society.
Source: Cancer - Category: Cancer & Oncology Authors: Lauren M. Hurwitz, Jennifer Cullen, Daniel J. Kim, Sally Elsamanoudi, Jane Hudak, Maryellen Colston, Judith Travis, Huai ‐Ching Kuo, Kevin R. Rice, Christopher R. Porter, Inger L. Rosner Tags: Original Article Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | External Beam Therapy | Prostate Cancer | Radiation Therapy | Study